VolitionRx (VNRX) News Today $0.68 +0.09 (+16.33%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period VolitionRx’s Nu.Q cancer test shows efficacy in lung cancer detectionDecember 11, 2024 | markets.businessinsider.comVolitionRx Limited (AMEX:VNRX) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comQ3 2024 VolitionRX Ltd Earnings Call TranscriptNovember 16, 2024 | gurufocus.comVolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...November 16, 2024 | gurufocus.comVolitionRx files $100M mixed securities shelfNovember 9, 2024 | markets.businessinsider.comQ2 2024 VolitionRX Ltd Earnings Call TranscriptAugust 18, 2024 | gurufocus.comVolitionRX Ltd (VNRX) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...August 18, 2024 | gurufocus.comVNRX Stock Earnings: VolitionRX Beats EPS, Misses Revenue for Q2 2024August 15, 2024 | markets.businessinsider.comVolitionRX earnings preview: what Wall Street is expectingMay 12, 2024 | markets.businessinsider.comNu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through AntechApril 23, 2024 | finance.yahoo.comVolitionRx Limited (VNRX) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | seekingalpha.comVolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comTELA Bio launches Liquifix surgical devices in the U.S.March 21, 2024 | msn.comVolition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in JapanMarch 20, 2024 | finance.yahoo.comVolition to Share Nu.Q® NETs Strategy Update at Upcoming WebinarFebruary 2, 2024 | finance.yahoo.comVolitionRx has 'compelling plans' to advance veterinary care in 2024January 6, 2024 | proactiveinvestors.comVolition Issues Business Review 2023January 4, 2024 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF), Universal Health (UHS) and VolitionRX (VNRX)January 3, 2024 | markets.businessinsider.comVolitionRx Limited Announces Third Quarter 2023 Financial Results and Business UpdateNovember 14, 2023 | finance.yahoo.comVNRX: Breakthrough Cancer Detection Method Disclosed at ESMO and in a Webinar - preliminary proof of concept work indicates simple blood test should be able to detect several types of cancer, potentially at Stages I & IINovember 2, 2023 | finance.yahoo.comVolitionRX (VNRX) Price Target Increased by 7.93% to 3.76November 1, 2023 | msn.comEF Hutton Initiates Coverage of VolitionRX (VNRX) with Buy RecommendationOctober 31, 2023 | msn.comCantor Fitzgerald Reaffirms Their Buy Rating on VolitionRX (VNRX)October 28, 2023 | markets.businessinsider.comVolitionRx hails study showing Nu.Q NETs promise as biomarker for septic shockOctober 19, 2023 | proactiveinvestors.comMeasuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic ShockOctober 19, 2023 | finance.yahoo.comVolitionRx welcomes US Ambassador to Belgium for exclusive tour of research facilitiesOctober 18, 2023 | proactiveinvestors.comUS Ambassador Adler visits Belgian VolitionOctober 18, 2023 | finance.yahoo.comVolitionRx to present cancer detection abstracts at European oncology conferenceOctober 16, 2023 | proactiveinvestors.comVolition Presents Three Cancer Detection Abstracts at ESMO 2023October 16, 2023 | finance.yahoo.comVolitionRx holds roundtable on sepsis managementOctober 13, 2023 | proactiveinvestors.comVolition Publishes Key Opinion Leader Roundtable Report on NETs in SepsisOctober 13, 2023 | finance.yahoo.comVolitionRx to unveil new cancer detection method insights at upcoming webinarOctober 4, 2023 | proactiveinvestors.comVolition to Reveal New Cancer Detection Method Insights at Upcoming WebinarOctober 2, 2023 | finance.yahoo.comVolitionRx, Avalo Therapeutic among healthcare moversSeptember 22, 2023 | msn.comVolition Hosts Key Opinion Leader Roundtable on Sepsis ManagementSeptember 13, 2023 | finance.yahoo.comVolitionRx (VNRX): Review of 2Q 2023; Distribution Footprint of Nu.Q Vet Cancer Test is expanding. Prolific Schedule of Clinical Papers & Posters.August 25, 2023 | finance.yahoo.comMaxim Group Reaffirms Their Buy Rating on VolitionRX (VNRX)August 23, 2023 | markets.businessinsider.comVolitionRx Limited Announces Second Quarter 2023 Financial Results and Business UpdateAugust 14, 2023 | finance.yahoo.comHere's what Wall Street expects from VolitionRX's earningsAugust 13, 2023 | markets.businessinsider.comVolitionRx: Equity raise reaches US$19.5mln as underwriter...VolitionRx: Equity raise reaches US$19.5mln as underwriter...June 26, 2023 | proactiveinvestors.comVolitionRx Limited prices major public offering to fund research and product developmentJune 1, 2023 | proactiveinvestors.comVolitionRx proposes public offeringJune 1, 2023 | msn.com8-K: VOLITIONRX LTDMay 12, 2023 | marketwatch.comVolitionRx reports cash and cash equivalents of $10M at 1Q-endMay 11, 2023 | proactiveinvestors.comVolitionRX Q1 2023 Earnings PreviewMay 10, 2023 | msn.comVolitionRX's Earnings OutlookMay 10, 2023 | msn.comVolitionRx Limited to Host Capital Markets Day at the NYSE on Thursday May 11.April 26, 2023 | finance.yahoo.comMaxim Group Sticks to Their Buy Rating for VolitionRX (VNRX)March 21, 2023 | markets.businessinsider.comVolitionRX Stock (AMEX:VNRX), Guidance and ForecastMarch 20, 2023 | benzinga.comVolitionRx Limited Schedules Full Year 2022 Earnings Conference Call and Business UpdateMarch 10, 2023 | finance.yahoo.com Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE! 👉 Yes, I Want the Free Report! 👈 VNRX Media Mentions By Week VNRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VNRX News Sentiment▼0.000.61▲Average Medical News Sentiment VNRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VNRX Articles This Week▼00▲VNRX Articles Average Week Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FitLife Brands News Seres Therapeutics News Adaptimmune Therapeutics News Black Diamond Therapeutics News Puma Biotechnology News Instil Bio News Telomir Pharmaceuticals News Galectin Therapeutics News Elutia News Compugen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:VNRX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
